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Glycation of the Major Milk Allergen β-Lactoglobulin
Changes Its Allergenicity by Alterations in Cellular Uptake
and Degradation
Marija Perusko, Manon van Roest, Dragana Stanic-Vucinic, Peter J. Simons,
Raymond H. H. Pieters, Tanja Cirkovic Velickovic, and Joost J. Smit*
Scope: During food processing, the Maillard reaction (МR) may occur,
resulting in the formation of glycated proteins. Glycated proteins are of
particular importance in food allergies because glycation may influence
interactions with the immune system. This study compared native and
extensively glycated milk allergen β-lactoglobulin (BLG), in their interactions
with cells crucially involved in allergy.
Methods and results: BLG was glycated in MR and characterized. Native and
glycated BLG were tested in experiments of epithelial transport, uptake and
degradation by DCs, T-cell cytokine responses, and basophil cell degranulation
using ELISA and flow cytometry. Glycation of BLG induced partial unfolding
and reduced its intestinal epithelial transfer over a Caco-2 monolayer. Uptake
of glycated BLG by bone marrow–derived dendritic cells (BMDC) was
increased, although both BLG forms entered BMDC via the same mechanism,
receptor-mediated endocytosis. Once inside the BMDC, glycated BLG was
degraded faster, which might have led to observed lower cytokine production
in BMDC/CD4+ T-cells coculture. Finally, glycated BLG was less efficient in
induction of degranulation of BLG-specific IgE sensitized basophil cells.
Conclusions: This study suggests that glycation of BLG by MR significantly
alters its fate in processes involved in immunogenicity and allergenicity,
pointing out the importance of food processing in food allergy.
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1. Introduction
Nowadays, the majority of food is sub-
jected to thermal treatment prior to con-
sumption, which induces structural and
chemical modifications of food proteins.
One of the most widespread modifica-
tions is glycation by the Maillard reac-
tion (MR), a very complex reaction cas-
cade that occurs between amino and
carbonyl groups.[1] Products of MR are
very diverse and give rise to a vari-
ety of glycation structures covalently at-
tached to food proteins that are collec-
tively termed as advanced glycation end-
products (AGEs). Glycated proteins pos-
sess many functional properties that are
relevant for food industry such as im-
proved gelling, emulsifying and foam-
ing activity, increased temperature and
pH stability, and increased antioxidant
activity,[2–6] but also characteristics that
are attractive for consumers such as ap-
pealing color, smell, taste, and texture.[7]
Apart from improving techno-
functional properties, MR also alters
biological and immunological properties of food proteins. It is
well documented that glycation of food allergens affects their
IgE binding ability by direct masking of linear as well as
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conformational epitopes, leading to reduced allergenicity.[8,9] In
contrast, other studies have pointed out that glycation led to for-
mation of neoantigens, hereby increasing their recognition by
IgE antibodies.[10–12] Recently, evidences are emerging that effects
of MR on food allergens go beyond IgE recognition. Dendritic
cells (DCs), as the most important antigen-presenting cells in
the immune system, possess several receptors that recognize gly-
cation structures, including receptor for advanced glycation end
products (RAGE), scavenger receptors (SRs), galectin-3, and CD-
36.[13,14] Acting through these receptors, glycation structures may
influence recognition, uptake, and processing of food allergens
by DCs. Subsequently, this may have consequences on the mat-
uration of DCs and subsequent activation of na¨ıve T-cells. For
instance, a glycated form of the major egg allergen, ovalbumin
(OVA) binds to SR class A which mediates increased allergen
uptake by DCs, and leads to a stronger T helper type 2 cytokine
response.[15,16] Similarly, AGE-BSA induced maturation of DCs
and augmented their capacity to stimulate T-cell proliferation and
cytokine secretion.[17] It has even been speculated that AGEs of
food allergens interact with DCs, promote immune responses,
and contribute to the development of food allergy by mimicking
endogenous danger signals.[18]
Very little is known about allergen processing and degrada-
tion inside DCs, despite that this is of great importance. It
has been described that the dynamics of uptake and degrada-
tion inside endolysosomal compartments of DCs affects class II
MHC loading pathways, antigen presentation, and finally T-cell
polarization.[19–21]
β-Lactoglobulin (BLG) is the most abundant whey protein
and one of the major allergens in milk.[22] Whey proteins are
frequently used as food additives because of their valuable nutri-
tional and techno-functional properties. Thus, they are very likely
to be glycated in MR upon food processing. There are scarce
literature data about the effects of the MR on the immunogenic
properties of the major whey allergen. Hence, the aim of this
study was to glycate BLGwith glucose to a high extent and to con-
duct a comparative analysis, relative to its native form, regarding
their behavior in processes that are involved in immunogenicity
and allergenicity. Intestinal epithelial transcytosis, uptake and
degradation by BMDCs, ability to induce cytokine production by
BLG-specific CD4+ T-cells, and basophil degranulation capacity
of native and glycated BLG were investigated.
2. Experimental Section
2.1. Chemicals and Standards
Unless otherwise stated, all chemicals were obtained from
Sigma-Aldrich (St. Louis, MO,USA). For all experiments, Milli-Q
water (Millipore, France) was used.
2.2. Mice
Five-week-old female C3H/HeOuJ mice were purchased
from Charles River (France) and were maintained in specific
pathogen-free conditions within the animal care facility at the
Utrecht University. Experiments were approved by the Animal
Experiments Committee of the Utrecht University.
2.3. Protein Sample Preparation
BLG was isolated from raw cow’s milk as described previously[23]
(details are given in supporting information). Purity of the ob-
tained BLG preparation was estimated to be >95% by SDS-
PAGE. Protein concentration was determined by bicinhoninic
acid (BCA) assay (Pierce, Amsterdam, the Netherlands). Endo-
toxin was reduced from samples by affinity chromatography on
ε-poly-l-lysine cellulose beads (Thermo Scientific, Rockford, IL).
The residual amount of endotoxin was determined using LAL
Chromogenic Endotoxin Quantitation Kit (Thermo Scientific,
Rockford, IL). The endotoxin concentration in BLG sample was
0.4 EU mg−1 of protein.
2.4. Glycation Procedure and Characterization of Glycated BLG
Glycated BLG was made by performing the MR in which 10 mg
mL−1 BLG was incubated with 180 mg mL−1 glucose in 50 mm
phosphate buffer, pH 8.0 at 60 ˚C for 10 days in capped vials.
Thermally treated BLG under the same conditions but without
glucose was also prepared. To determine the degree of glycation,
free amino groups were estimated by the ortho-phthalaldehyde
(OPA) method as described previously.[24] To further characterize
glycated BLG, SDS-PAGE was performed on 14% gel (5 μg of
protein per lane, under reducing and nonreducing conditions.
Protein bands were visualized by Coomassie Brilliant Blue
staining. Structural changes were monitored by recording far-
UV CD spectra on a JASCO J-815 spectropolarimeter (JASCO,
Tokyo, Japan) of 0.85 mg mL−1 native and glycated BLG in
50 mm sodium phosphate buffer pH 8.0. Each spectrum was
acquired four times, and the results were averaged. Spectra were
analyzed by the CONTIN program to determine the proportion
of secondary structures based on reference protein set of 29
soluble proteins—SP29 as previously was done.[23]
2.5. Caco-2 Cell Culture
The culturing of Caco-2 cells is described in supporting informa-
tion.
2.6. Transport Across Caco-2 Cell Monolayer
For transport studies, Caco-2 cells were seeded at 1.6 × 104
cells per insert on polycarbonate membranes with a pore size
of 0.1 μm in 24-well plates (Transwell, Corning Costar, Cam-
bridge,MA). Cells at passages of 17–25were used in experiments.
Prior to the transport studies, transepithelial electrical resistance
(TEER) was measured using Millicell-ERS VoltOhmmeter (Mil-
lipore, Amsterdam, the Netherlands). Only cell monolayers with
TEER >500  were used. Native and glycated BLG were diluted
in DMEM culture medium to a final concentration of 1.5 mg
mL−1, and 100 μL of these preparations were loaded onto api-
cal surface of Caco-2 monolayer, while 600 μL of DMEM cul-
ture medium was added to the receiver compartment. Aliquots
of 30 μL were withdrawn from the receiver compartment after
15, 30, 60, 120, 240, and 300 min and receiver compartment was
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replenished every timewithmedium. Transported native and gly-
cated BLG were detected by commercially available ELISA kit
(Bethyl Laboratories, Inc., Montgomery) according to manufac-
turer’s instructions.
2.7. Generation of Bone Marrow–Derived Dendritic Cells
(BMDCs)
Bone marrow cells isolated from femurs/tibias of na¨ıve
C3H/HeOuJ mice were cultured in conditioned-complete DCs
medium (RPMI 1640 medium glutaMAX [Gibco, Invitrogen,
Carlsbad, USA]) supplemented with 10% heat-inactivated FCS,
1 mm sodium pyruvate, 100 units mL−1 penicillin, 100 μg
mL−1 streptomycin, 1% nonessential amino acids, 0.1 mm
2-mercaptoethanol), with 10 ng mL−1 GM-CSF (R&D, Oxon,
UK) at 37 °C in a humidified atmosphere of 5% CO2. Medium
was refreshed on day 3. Only 6 days old BMDCs were used for
the following experiments.
2.8. Allergen Uptake by BMDCs
Native and glycated BLG were labeled with FITC according to
the manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO,
USA). FITC-native BLG and FITC-glycated BLG conjugates were
separated from unreacted FITC label using PD-10 desalting col-
umn (GE Healthcare, Uppsala, Sweden). The labeling efficacy
was the same for native and glycated BLG as determined by ab-
sorbance at 280 and 495 nm. The concentration of labeled sam-
ples was determined by BCA assay, and the samples were stored
protected from light at −20 °C until use.
FITC-native and FITC-glycated BLG (10 μg mL−1) were incu-
bated with 1 × 106 BMDCs per mL of cell culture medium for
0, 5, 10, 20, 30, 45, 60, 90, and 120 min at 37 °C. Uptake was
recorded using BD Accuri C6 Cytometer (BD Biosciences, San
Jose, CA, USA). Mean fluorescence intensity (MFI) and percent-
age of FITC-positive BMDCs were calculated using BDAccuri C6
software.
2.9. Mechanistic Studies of Allergen Uptake by BMDCs
To identify uptake mechanism for native and glycated BLG,
BMDCswere pretreatedwith 10μgmL−1 latrunculin B, 1μm jas-
plakinolide, 2mm amiloride, 2μmphenylarsine oxide, inhibitors
of phagocytosis, macropinocytosis, and receptor-mediated endo-
cytosis, respectively. To inhibit uptake mediated by specific re-
ceptors, BMDCs were incubated with the following inhibitors:
100μgmL−1 dextran sulfate, or 200μgmL−1 polyinosine specific
for SRs, and 0.3 μm FPS-ZM1 specific for RAGE. After 30 min
of incubation at 37 °C with the above inhibitors, BMDCs were
loaded with 10 μg mL−1 FITC-native BLG and FITC-glycated
BLG. Uptake was recorded after 30 min of incubation at 37 °C
by flow cytometry as described above.
2.10. Confocal Microscopy
1× 105 BMDCs in the presence or absence of different inhibitors
under above described conditions were withdrawn, washed,
and spun onto glass slides by cytospin. Cells were imaged on
a Leica TCS SPE-2 confocal laser scanning-microscope on a
DMI4000.
2.11. Endolysosomal Degradation Assay
Native and glycated BLG were covalently coupled to polystyrene
beads (Polysciences, Inc., Warrington, PA, USA) (protocol in-
cluded in supporting material).
Endolysosomal degradation was estimated according to Hoff-
mann et al.[25] with minor modifications. Total of 12.5 × 106
BMDCs from na¨ıve mice were incubated with 50 × 106 of na-
tive and glycated BLG-coated beads at 37 °C for 15 min to al-
low phagocytosis. Phagocytosis was stopped by adding ice-cold
PBS. Non-internalized beads were washed out three times with
FCS floatation cushion at +4 °C. BMDCs were resuspended in
2.5 mL of conditioned-complete DCs medium and incubated at
37 °C to start phagosome maturation. Aliquots of 480 μL were
withdrawn after 0, 30, 120, 240, and 720 min and immediately
mixed with 1 mL of ice-cold PBS to stop phagosome maturation,
and centrifuged for 5 min at 400 g at 4 °C. Pelleted BMDCs were
lysed with lysis buffer (50 mm Tris, 150 mm NaCl, 0.5% Triton x,
1mmDTT, 10μgmL−1 Dnase I, pH7.4, with the addition of com-
plete protease inhibitor cocktail [Roche, Lewes, UK]), overnight,
at 4 °C. Non-degraded BLG on the beads surface was detected us-
ing rabbit polyclonal anti-BLG antibody 1:1000 (Fitzgerald, 70R-
LR011) and anti-rabbit Alexa 488 antibody (Invitrogen A11034).
Alexa intensity was measured by flow cytometry.
2.12. Assessment of T-cell Activation and Cytokine Production
BLG-specific CD4+ T-cells were obtained from spleens of
C3H/HeOuJ mice immunized with BLG and aluminum hydrox-
ide (Imject Alum, Pierce, the Netherlands). On days 0 and 7,
three mice were intraperitoneally injected with 100 μg of native
BLG and 1 mg of ALUM. On day 14, BMDCs from na¨ıve mice
were primed with 50 μg mL−1 of different forms of BLG for 2 h.
BMDCs were scraped, washed, and transferred to a 48-well plate
where they were cocultured (1:10 cell number ratio) with freshly
isolated CD4+ T-cells for the next 72 h. Subsequently, levels
of IFN-γ , IL-5, IL-10, and IL-13 were measured in coculture
supernatants by commercially available ELISA (e-Bioscience,
Austria).
2.13. Anti-BLG IgE Crosslinking-Induced NFAT-Responsive
Luciferase in Basophilic RS-ATL8 Cells
The humanized rat basophilic leukemia cell line RS-ATL8 was
kindly provided by R. Nakamura from the National Institute for
Health Sciences, Tokyo, Japan. This cell line which was estab-
lished by introducing the NFAT-responsive luciferase gene into
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human FcεRI expressing RBL-SX38 cells was used to measure
IgE crosslinking-induced luciferase expression (EXiLE). EXiLE
assay was performed as described previously[26] with slight
modifications. RS-ATL8 cells (5× 104 cells per 50 μL per well) in
96-wells flat bottom culture plate were sensitized overnight with
a pool of six anti-BLG chimeric IgE monoclonal antibodies (1 μg
mL−1 each individual humanized IgE).[27] Cells werewashed once
with sterile PBS and then stimulated for 1 h at 37 °C in a 5% CO2
incubator with 50 μL per well of native and glycated BLG diluted
in MEM containing 10% FCS in four different concentrations (1,
10, 100, and 1000 ng mL−1) or with 1 μg mL−1 goat anti-human
IgE antibodies (DakoCytomation, Glostrup, Denmark) as con-
trol. After stimulation, 50 μL of luciferase substrate solution
containing cell lysis reagent (ONE-Glo, Promega Corp., Tokyo,
Japan) was added to the cells, and chemiluminescence was mea-
sured. Luciferase expression levels are represented as the fold
increase of relative light units compared with the background
expression.
2.14. Statistical Analysis
Data are presented as mean ± stand deviation (SD) or standard
error of mean (SEM) and analyzed using GraphPad Prism soft-
ware (La Jolla, CA). Data were tested by Student’s t-test. Differ-
ences were considered significant when p-values were <0.05.
3. Results
3.1. BLG Was Glycated to a High Extent Accompanied by
Modifications in Secondary Structure
BLG was glycated with glucose in the MR, and the degree of gly-
cationwas assessed by determining the free amino group content
by OPAmethod (Figure 1A). A significant loss of available amino
groups was observed; about 75% of amino groups were glycated.
Analysis of native and glycated BLG by SDS-PAGE showed a
band at 18 kDa, corresponding to BLG (Figure 1B). This band
smeared toward higher molecular masses after conjugation with
glucose molecules. Under nonreducing conditions, BLG dimers
were present in both, native and glycated BLG, while under re-
ducing conditions, native BLG was visible only in monomeric
form, but glycated BLG was still visible in dimeric form, indicat-
ing the formation of covalent bonds other than disulfide bridges.
Glycation reaction also induced covalent aggregates formation,
noticeable as higher molecular masses at the interface of stack-
ing and running gels.
Changes were observed in far-UV CD spectra of glycated BLG
compared to native BLG spectra (Figure 1C). The characteristic
minimum of native BLG at 215 nm was shifted toward a lower
wavelength, indicating a decrease in the ordered secondary struc-
ture. Software analysis of CD spectra showed a decrease inα-helix
accompanied with an increase in random coils (Figure 1D), sug-
gesting a direct conversion of regular into irregular structures
upon glycation.
In addition, thermal treatment of BLG without glucose led
to different changes in structure and a higher extent of aggre-
gate formation in comparison to glycated BLG, as evidenced by
SDS-PAGE under reducing and nonreducing conditions (Figure
S1A,B, Supporting Information). Also, far-UV CD spectra anal-
ysis showed differences in the structural change of heated and
glycated BLG in comparison to native BLG. Heated BLG showed
a significantly higher loss of β-sheets (Figure S2A,B, Supporting
Information). The protective effect of sugar on the heat-induced
denaturation and aggregation of BLGhas been shown extensively
before.[5,24,28,29] Therefore structural changes induced by Maillard
reaction are not simply the sum of thermally induced structural
changes and covalent attachment of sugar moieties. Thus, native
BLG, rather than heated BLG, was used as control in order to
compare their interactions with immune cells crucially involved
in cow‘s milk allergy.
3.2. Glycation of BLG Reduced Transport Across Caco-2 Cell
Monolayer
Transport of BLG samples across Caco-2 cell monolayer, a model
of intestinal barrier function, was examined. Native and glycated
BLG were applied on apical side of Caco-2 cells and transport
was followed in time by determining BLG concentration on basal
side. Glycation reaction dramatically reduced detection of BLG
at basolateral side of Caco-2 monolayer (Figure 2). Transport of
both native and glycated BLG was continuous, verifying intact-
ness of Caco-2 monolayer and preserved tight junctions during
experiment.
3.3. Glycation of BLG Increased Uptake by BMDCs
Further, we investigated whether glycation through MR influ-
ences interactions of BLG with BMDCs. FITC-labeled native and
glycated BLG were incubated with BMDCs, and BLG uptake was
followed in time by flow cytometry. Uptake of both BLG forms,
measured as percent of FITC-positive cells (Figure 3A) was time
dependent and reached plateau after 30 min, while the MFI (Fig-
ure 3B) continuously increased up to 120min. Glycated BLG was
taken upmore efficiently reaching 85% of FITC-positive BMDCs
compared to 55% when incubated with native BLG. Significantly
increased uptake of glycated BLG was also observed when MFI
was measured.
Confocalmicrographs were in agreement with the findings ob-
tained by flow cytometry, BMDCs displayed a higher fluorescent
signal upon incubation with glycated BLG (Figure 3C).
3.4. Glycated BLG Entered BMDCs via Receptor-Mediated
Endocytosis, Involving Scavenger Receptors
To understand the process of uptake by BMDCs of native and
glycated BLG, we inhibited several possible uptake routes.
First, BMDCs were incubated at 4 °C to stop all active cellular
processes. This led to almost complete reduction of native and
glycated BLG uptake (Figure 4A), indicating that the uptake was
active and by an energy dependent process. Second, pretreat-
ment with latrunculin B and jasplakinolide, which are known to
interfere with actin polymerization and therefore inhibit phago-
cytosis, reduced uptake of both BLG forms (Figure 4A,C). This
Mol. Nutr. Food Res. 2018, 62, 1800341 1800341 (4 of 12) C© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.advancedsciencenews.com www.mnf-journal.com
Figure 1. Characterization of BLG glycated in MR. A) Estimation of the degree of MR by determining remaining free amino group content by OPA
method. Free amino group content was statistically compared by Student’s t-test. ****Denotes significance at p < 0.0001 confidence level. B) Protein
profile of native and glycated BLG on 14% SDS-PAGE gel under nonreducing (NR) and reducing (R) conditions. Protein bands were stained with CBB.
1) native BLG; 2) glycated BLG; 3) molecular weight markers (kDa). C) CD spectra of native and glycated BLG in far-UV spectral range. Samples were
recorded in 50 mm sodium phosphate buffer, pH 8.0 at protein concentration 0.85 mg mL. D) Percentages of the secondary structures were estimated
by CONTIN algorithm available in CDPro package based on SP29 reference set. Secondary structure fractions were compared by Student’s t-test.
*Represents significance at p < 0.05 confidence level.
suggested that actin and phagocytosis were involved in the up-
take process. Third, amiloride, an inhibitor of macropinocytosis,
also decreased uptake of both BLG forms (Figure 4A,C). Final,
pretreatment of BMDCs with phenylarsine oxide, an inhibitor of
the internalization of cell surface receptors, resulted in a strong
inhibition of the endocytosis of native BLG, while almost com-
pletely abrogated uptake of glycated BLG (Figure 4A,C). Taken
together, inhibition studies showed that native and glycated BLG
entered BMDCs in actin-dependent process and phagocytosis,
by constitutive macropinocytosis and by receptor-mediated
endocytosis.
Additionally, in an attempt to identify receptor(s) involved in
the uptake of native and glycated BLG, inhibitors for specific
endocytic receptors were used. Both dextran sulfate and polyino-
sine, inhibitors of SRs, remarkably reduced the uptake of both
BLG forms (Figure 4B,D). Treatment of BMDCs with FPS-ZM1,
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Figure 2. Bioavailability of native and glycated BLG in vitro. Transcytosis
of native and glycated BLG across Caco-2 monolayer. Transport was mea-
sured by determining BLG concentration in samples withdrawn from ba-
solateral chamber at different time-points up to 3 h. Each point represents
mean ± SD. One representative experiment out of three independent is
shown. *, **, and *** represent significance at p < 0.05, 0.01, and 0.001,
respectively.
a RAGE inhibitor, did not significantly affect uptake of any
BLG form (Figure 4B,D). This suggests that both BLG forms
bind to and being internalized via SRs at least to some extent.
Redirection of glycated BLG uptake toward receptor-mediated
endocytosis could be caused by stronger recognition by SRs
due to changes in physicochemical properties that followed
the MR.
3.5. Glycated BLG Showed Higher Susceptibility to
Endolysosomal Degradation Inside BMDCs
Efficient intracellular antigen degradation and processing is
of crucial importance for antigen presentation. We therefore
compared endolysosomal proteolysis of native and glycated BLG
within BMDCs. BMDCs were allowed to phagocytose native
and glycated BLG coupled to polystyrene beads, and endolyso-
somal degradation of allergens was determined by BLG-specific
Figure 3. BMDCs uptake of FITC-labeled native and glycated BLG followed in time. BMDCs were incubated with 10 μg mL−1 FITC-labeled native and
glycated BLG for 120 min and the BMDC uptake was analyzed by means of flow cytometry. Data are expressed as A) percent of FITC-positive BMDCs
and B) MFI. ** and **** represent significance at p < 0.01 and 0.0001, respectively. C) Confocal micrographs of BMDC incubated with FITC-labeled
native and glycated BLG for 30 min.
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Figure 4. Mechanistic studies of uptake of FITC-labeled native and glycated BLG in the presence of different inhibitors. BMDCs were pre-incubated
for 30 min with A) mechanism-specific inhibitors, namely: latrunculin B—inhibitor of actin polymerization; jasplackinolide—inhibitor of phagocytosis;
amiloride—macropinocytosis inhibitor; phenylarsine oxide—inhibitor of receptor-mediated endocytosis, or with B) receptor-specific inhibitors: dextran
sulfate and polyinosine—SRs inhibitors; FPS-ZM1—RAGE inhibitor. Subsequently, cells were loaded with 10 μg mL−1 FITC-labeled native and glycated
BLG. BMDCs uptake was analyzed by flow cytometry, and data are represented as percent of MFI of non-inhibited uptake as mean ± SEM (n = 6) and
analyzed by Student’s t-tests. **, ***, and **** represent significance at p < 0.01, 0.001, and 0.0001, respectively. Mechanistic studies in the presence
of C) mechanism-specific inhibitors or D) receptor-specific inhibitors were additionally followed by confocal microscopy.
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Figure 5. Kinetics of endolysosomal degradation of native and glycated BLG. BMDC were allowed to internalize native and glycated BLG-coated
polystyrene beads and incubated for different periods at 37 °C to allow endolysosomal degradation. After every time-point, cells were lysed and beads
carrying non-degraded BLG were stained by Alexa 488 BLG-specific antibodies. Polystyrene beads were analyzed by flow cytometry. A) Flow cytometry
dot plot of one representative experiment. B) Percentage of non-degraded native and glycated BLG over time is shown as mean ± SEM (n = 4). ****
denotes significance at p < 0.0001 confidence level.
antibody binding. Significant lower antibody binding to glycated
BLG after first 30 min of degradation indicated that glycation
influenced degradation kinetics, making glycated protein more
susceptible to proteolysis especially at first time (Figure 5).
3.6. Glycated BLG Induced Lower CD4+ T-Cell Cytokine
Responses
To assess the specific T-cell responses to glycated BLG, BLG-
specific CD4+ T-cells were isolated from mice immunized to
native BLG and cocultured with BMDCs primed with native or
glycated BLG. After coculture, glycated BLG-primed BMDCs in-
duced lower production of INF-γ , IL-5, and IL-13 by T-cells, when
compared with native BLG-primed BMDCs (Figure 6). Both
native and glycated BLG-primed BMDCs equally induced IL-10
production.
3.7. Glycation of BLG Reduced Basophil Activation
Finally, to gain insight into the effects of glycated BLG on allergic
effector responses, a basophil cell elicitation test was performed.
RS-ATL8 cells were sensitized with oligoclonal anti-BLG-specific
humanized IgE antibodies and subsequently native or glycated
BLG was added. Glycated BLG induced significantly lower ba-
sophil activation compared to native BLG at all tested concentra-
tions (Figure 7).
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Figure 6. Stimulation of BLG-specific CD4+ T-cells by native or glycated BLG-primed BMDCs. CD4+ T-cells isolated from C3H/HeOuJ mice immunized
with native BLGwere cocultured with BMDCs primed with native or glycated BLG for 72 h. Levels of INF-γ , IL-5, IL-10, and IL-13 in coculture supernatants
were measured by ELISA. The data are presented as mean ± SD of one representative experiment and analyzed by Student’s t-test. **, ***, and ns,
represent p < 0.01, 0.001, and not significant, respectively.
4. Discussion
Thermally processed food is highly consumed in theWestern diet
nowadays. Food processing can induce multiple biochemical re-
actions in food including MR which cause glycation of food pro-
teins and formation of AGEs. Glycation of food allergens may
have an impact on allergenicity but there is no conclusive data on
how these modifications alter allergenic manifestations. The im-
munomodulatory effects of AGEs structures have been described
in literature (reviewed in refs. 18,30–33). For instance, the effects
ofMR on immunogenicity and allergenicity of food allergenOVA
have also been studied and have shown an elevated risk of food
allergy.[15,16,34] We aimed to describe how glycation reaction of the
majormilk allergen, BLG, influences handling and processing by
epithelial and dendritic cells.
In order to exert a possible immunological effect, glycated pro-
teins must be able to pass the intestinal epithelial barrier and to
get in contact with immune system. Transport of allergens can
occur transcellularly or paracellularly through intestinal epithe-
lial cells. The main route of in vivo intestinal absorption of native
BLG is through epithelial cells.[35,36] We compared the transfer
of native and glycated BLG using the well-known in vitro Caco-2
cell monolayer system for testing intestinal barrier function. We
showed that both native and glycated BLG are able to cross the
Caco-2 monolayer, although the MR drastically reduced transcy-
tosis of BLG. This could have been caused by the physicochemi-
cal changes in BLG induced by glycation, such as partial unfold-
ing, and formation of high molecular weight species which can
make transcytosis more difficult. Reduced intestinal permeabil-
ity would result in lower allergen uptake and may hence reduce
activation of sensitized lamina propriamast cells and subsequent
anaphylactic responses.[37] Roth et al. reported that pasteurization
of the BLG and α-lactalbumin protected against an anaphylactic
reaction, since uptake through epithelial cells was impaired due
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Figure 7. IgE crosslinking-induced luciferase expression assay demon-
strating basophil activation by native and glycated BLG. RS-ATL8 cells were
sensitized with the pool of BLG-specific chimeric human IgE monoclonal
antibodies and subsequently stimulated with 1, 10, 100, or 1000 ng mL−1
of native and glycated BLG. Luciferase expression level after 1 h of stimu-
lation is shown. Dashed line shows luciferase expression after stimulation
with 1 μg mL−1 anti-human IgE antibodies. Data are expressed as mean
± SD (n = 8) and analyzed by t-tests. *p < 0.05.
to aggregation.[36] Furthermore, in our basophil activation exper-
iments, glycation of BLG reduced its capacity to crosslink FcεRI
receptors on RBL cells. In extensively glycated BLG, all residues
containing free amino group (16 lysines, two arginines, and N-
terminal amino group of Leu 1) seem to be glycated,[38,39] while
all of the BLG-specific chimeric human IgE monoclonal antibod-
ies used in this study recognize peptides containing at least 1–2
residues with possible glycation sites.[27] Therefore, it is highly
likely that extensive BLG glycation reduced mAb IgE binding by
changing epitope structure, and led to reduced basophil activa-
tion. Additionally, previous studies showed a masking effect of
glycation with different monosaccharides on IgE binding prop-
erties of BLG.[8] This effect of high degree of glycation on the
recognition of food allergens by IgE antibodies has been well doc-
umented in literature.[8,9,40] Lower allergic effector responses (as
measured by ability to induce crosslinking of FcεRI receptors),
together with much lower intestinal transport (as measured in
transcytosis Caco-2 experiment) suggest that glycation of BLG re-
duces the risk of allergic or even anaphylactic reactions.
To further characterize the down-stream processing of gly-
cated BLG, we examined its uptake and degradation by murine
BMDCs. We found that the uptake of glycated BLG by imma-
ture BMDCs was significantly increased, compared to uptake of
native BLG, at every measured time-point. The same was ob-
served for uptake of glycated OVA by either murine BMDCs or
human myeloid DCs.[15,16,34] In addition, we used pharmacologi-
cal inhibitors which interfere with different internalization path-
ways. Phenylarsine oxide inhibited the uptake of both native and
glycated BLG, indicating that receptor-mediated endocytosis is
involved in internalization process. The more pronounced in-
hibition of glycated BLG uptake, compared to inhibition of na-
tive BLG uptake, in the presence of phenylarsine oxide indicates
a shift of glycated BLG uptake to receptor-mediated endocyto-
sis. To execute their role, BMDCs are equipped with a full array
of specialized receptors, including pattern-recognition receptors
(PRRs) such as toll-like receptors (TLRs), C-type lectins (CTLs),
and SRs. Literature suggests that some allergens interact with
PRR and thereby stimulate innate and adaptive responses.[41]
Considering their role in recognizing glycated products, we selec-
tively blocked SRs and RAGE and found that SRs were respon-
sible for the uptake of both native and glycated BLG. Our find-
ings are in accordance with previously published data that AGEs
structures of glycated proteins bind to SR class A.[34,42] Interest-
ingly, SRs ligands are polyanionic molecules[43] and BLG is an
acidic protein with pI value 5.1, which can explain its binding to
SRs. Blocking of lysyl residues by sugarmoieties inMR lowers pI
value andmakes glycated BLG evenmore acidic, possibly leading
to higher binding affinity for SRs and consequently higher up-
take by BMDCs. Another factor influencing faster uptake could
be changed folding and increased aggregation that accompanied
the glycation reaction. Similarly, pyrraline, an AGEs structure,
when attached to OVA has been suggested to promote SR class
A-mediated allergen uptake by DCs.[34]
In spite of the much higher uptake by BMDCs through SR-
mediated endocytosis, glycated BLG showed lower CD4+ T-cell
stimulation. Glycated BLG-primed BMDCs in coculture with
BLG-specific CD4+ T-cells showed significantly lower production
of Th1- (INF-γ ) and Th2-type cytokines (IL-5 and IL-13) when
compared with native BLG-primed BMDCs. This indicated that
there was less peptide loading of MHC class II when BMDCs
were primed with glycated BLG. Previously published results,
showing that glycated OVA was taken up by DCs via SR class A
type I and type II-mediated endocytosis, followed with enhanced
CD4+ T-cell responses,[15] are in contrast with our findings and
indicate that overall effect on T-cell responses is carbohydrate-
and allergen-dependent. These findings also stress the impor-
tance of events that follow antigen internalization, that is, antigen
processing and activation of downstream signaling pathways. In
support of our observations, Smole et al. reported that immature
monocyte-derived DCs were able to internalize potent allergen
Bet v 1 and its structural homolog, but weak allergen, Api g 1
with the similar kinetics, and furthermore, there was no differ-
ence in the uptake by DCs from healthy or allergic donors.[44]
We showed increased susceptibility of glycated BLG to endolyso-
somal proteolysis. Glycation of BLG increased content of ran-
dom structures (as shown by CD spectroscopy), reducing its fold
stability and making polypeptide backbone more accessible to
endolysosomal proteases. Intracellular antigen degradation in
antigen-presenting cells determines the antigen fate.[45] Antigens
highly susceptible to endolysosomal proteases are known to pos-
sess weak capacity of T-cell priming.[46] This could explain the
observed decreased T-cell stimulation by glycated BLG.
In conclusion, in this study, we found that BLG glycated
in MR showed reduced transepithelial transport, but higher
uptake by BMDC. It appeared that both native and glycated BLG
can be endocytosed by BMDCs via SRs, but MR made BLG a
better ligand for SRs possibly through lowering pI value and
aggregates formation and thus increased its uptake. Glycated
BLG was more prone to endolysosomal degradation and showed
lower potential to induce cytokine production in coculture of
BMDCs with BLG-specific CD4+ T-cells. Glycated BLG also
induced lower effector response, that is, reduced basophil
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activation. Altogether, our results showed that glycation of BLG
influences its interactions with cells involved in the (allergic)
immune response, and also that glycated BLG could be less
potent in the induction of Th2 type responses in a host primarily
sensitized to native BLG. Interestingly, up to now, literature data
about sensitizing potential of glycated BLG are still missing.
Future studies are needed to elucidate the importance of MR on
allergenicity and immunogenicity of BLG in vivo. The present
study contributes to the knowledge regarding the effects of food
processing on food allergies and it is of great importance for
considerations of pros and cons of food processing.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
Acknowledgements
This work was supported by the GA No. 172024 of the Ministry of Edu-
cation, Science and Technological Development. M.P.’s research visit to
the Institute for Risk Assessment Sciences was supported by COST Ac-
tion FA1402. The authors thank R. Nakamura (National Institute of Health
Sciences, Tokyo, Japan) and F. H. Falcone (University of Nottingham, Not-
tingham, UK) for supplying the RS-ATL8 reporter system.M.P. participated
in all stages of the project, did the experiments, interpreted data, and was
the main author of the manuscript; M.R. participated in carrying out the
experiments; D.S.-V., P.J.S., R.P., and T.C.V. contributed with interpretation
of the data; J.J.S. designed the study and interpreted data. All authors con-
tributed to the manuscript.
Conflict of Interest
The authors declare no conflict of interest.
Keywords
β-lactoglobulin, food allergens, food processing, Maillard reaction, uptake
and degradation by DCs
Received: April 6, 2018
Revised: June 27, 2018
Published online: July 30, 2018
[1] T. Henle, Amino Acids 2005, 29, 313.
[2] M. J. Spotti, M. J. Perduca, A. Piagentini, L. G. Santiago, A. C. Rubiolo,
C. R. Carrara, Food Hydrocoll. 2013, 31, 26.
[3] D. Zhu, S. Damodaran, J. A. Lucey, J. Agric. Food Chem. 2010, 58,
2988.
[4] Z. Herceg, A. Rezˇek, V. Lelas, G. Kresˇi´c, M. Franetovi´c, J. Food Eng.
2007, 79, 279.
[5] G. Liu, Q. Zhong, J. Agric. Food Chem. 2012, 60, 9754.
[6] Y. Yilmaz, R. Toledo, Food Chem. 2005, 93, 273.
[7] J. P. Danehy, Adv. Food. Res. 1986, 30, 77.
[8] A. Taheri-Kafrani, J. C. Gaudin, H. Rabesona, C. Nioi, D. Agarwal, M.
Drouet, J. M. Chobert, A. K. Bordbar, T. Haertle, J. Agric. Food Chem.
2009, 57, 4974.
[9] P. Gruber, S. Vieths, A. Wangorsch, J. Nerkamp, T. Hofmann, J. Agric.
Food Chem. 2004, 52, 4002.
[10] S. J. Maleki, S. Y. Chung, E. T. Champagne, J. P. Raufman, J. Allergy
Clin. Immunol 2000, 106, 763.
[11] A. Nakamura, K. Watanabe, T. Ojima, D. H. Ahn, H. Saeki, J. Agric.
Food Chem. 2005, 53, 7559.
[12] P. Gruber, W. M. Becker, T. Hofmann, J. Agric. Food Chem. 2005, 53,
2289.
[13] Y. Li, T. Mitsuhashi, D. Wojciechowicz, N. Shimizu, J. Li, A. Stitt, C.
He, D. Banerjee, H. Vlassara, Proc. Natl. Acad. Sci. U. S. A. 1996, 93,
11047.
[14] A. Miyazaki, H. Nakayama, S. Horiuchi, Trends Cardiovasc. Med. 2002,
12, 258.
[15] A. Ilchmann, S. Burgdorf, S. Scheurer, Z. Waibler, R. Nagai, A. Well-
ner, Y. Yamamoto, H. Yamamoto, T. Henle, C. Kurts, U. Kalinke, S.
Vieths, M. Toda, J. Allergy Clin. Immunol. 2010, 125, 175.
[16] T. Hilmenyuk, I. Bellinghausen, B. Heydenreich, A. Ilchmann, M.
Toda, S. Grabbe, J. Saloga, Immunology 2010, 129, 437.
[17] J. Ge, Q. Jia, C. Liang, Y. Luo, D. Huang, A. Sun, K. Wang, Y. Zou, H.
Chen, Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2157.
[18] P. K. Smith, M. Masilamani, X. M. Li, H. A. Sampson, J. Allergy Clin.
Immunol. 2016, 139, 429.
[19] R. Freier, E. Dall, H. Brandstetter, Sci. Rep. 2015, 5, 12707.
[20] Y.Machado, R. Freier, S. Scheiblhofer, T. Thalhamer,M.Mayr, P. Briza,
S. Grutsch, L. Ahammer, J. E. Fuchs, H. G. Wallnoefer, A. Isakovic, V.
Kohlbauer, A. Hinterholzer, M. Steiner, M. Danzer, J. Horejs-Hoeck,
F. Ferreira, K. R. Liedl, M. Tollinger, P. Lackner, C. M. Johnson, H.
Brandstetter, J. Thalhamer, R. Weiss, J. Allergy Clin. Immunol. 2016,
137, 1525.
[21] D. Stanic-Vucinic, M. Stojadinovic, I. Mirkov, D. Apostolovic, L. Bu-
razer, M. Atanaskovic-Markovic, M. Kataranovski, T. Cirkovic Velick-
ovic, RSC Adv. 2016, 6, 88216.
[22] J. Wal, Allergy 2001, 56, 35.
[23] M. Stojadinovic, L. Burazer, D. Ercili-Cura, A. Sancho, J. Buchert,
T. Cirkovic Velickovic, D. Stanic-Vucinic, J. Sci. Food Agric. 2012, 92,
1432.
[24] M. Perusko, A. Al-Hanish, T. Cirkovic Velickovic, D. Stanic-Vucinic,
Food Chem. 2015, 177, 248.
[25] E. Hoffmann, A.-M. Pauwels, A. Alloatti, F. Kotsias, S. Amigorena,Bio.
protoc. 2016, 6, e2014.
[26] E. A. Ali, R. Nakamura, F. H. Falcone,Methods Mol. Biol. 2017, 1592,
147.
[27] K. Knipping, P. J. Simons, L. S. Buelens-Sleumer, L. Cox, M. den Har-
tog, N. de Jong, R. Teshima, J. Garssen, L. Boon, L. M. Knippels, PLoS
One 2014, 9, e106025.
[28] J.-H. Seo, A. Hedoux, Y. Guinet, L. Paccou, F. Affouard, A. Lerbret, M.
Descamps, J. Phys. Chem. B 2010, 114, 6675.
[29] Y. Chen, X. Chen, T. L. Guo, P. Zhou, Food Res. Int. 2015, 69, 106.
[30] R. K. Gupta, K. Gupta, A. Sharma, M. Das, I. A. Ansari, P. D. Dwivedi,
Crit. Rev. Food Sci. and Nutr. 2016, 58, 208.
[31] M. Toda, M. Heilmann, A. Ilchmann, S. Vieths, Clin. Chem. Lab. Med.
2014, 52, 61.
[32] M. Teodorowicz, J. van Neerven, H. Savelkoul, Nutrients 2017, 9,
E835.
[33] P. K. Smith, Curr. Opin. Allergy Clin. Immunol. 2017, 17, 325.
[34] M. Heilmann, A. Wellner, G. Gadermaier, A. Ilchmann, P. Briza, M.
Krause, R. Nagai, S. Burgdorf, S. Scheurer, S. Vieths, T. Henle, M.
Toda, J. Biol. Chem. 2014, 289, 7919.
[35] M. Stojadinovic, R. Pieters, J. Smit, T. C. Velickovic, Toxicol. Sci. 2014,
140, 224.
[36] F. Roth-Walter, M. C. Berin, P. Arnaboldi, C. R. Escalante, S. Dahan, J.
Rauch, E. Jensen-Jarolim, L. Mayer, Allergy 2008, 63, 882.
[37] K. R. Groschwitz, S. P. Hogan, J. Allergy Clin. Immunol. 2009,
124, 3.
Mol. Nutr. Food Res. 2018, 62, 1800341 1800341 (11 of 12) C© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.advancedsciencenews.com www.mnf-journal.com
[38] F. Fenaille, F. Morgan, V. Parisod, J. C. Tabet, P. A. Guy, J. Mass Spec-
trom. 2004, 39, 16.
[39] Y. J. Chen, L. Liang, X. M. Liu, T. P. Labuza, P. Zhou, J. Agric. Food
Chem. 2012, 60, 106.
[40] A. Nakamura, K. Watanabe, T. Ojima, D.-H. Ahn, H. Saeki, J. Agric.
Food Chem. 2006, 54, 9529.
[41] S. Scheurer, M. Toda, S. Vieths, Clin. Exp. Allergy 2015, 45, 1150.
[42] N. Araki, T. Higashi, T. Mori, R. Shibayama, Y. Kawabe, T. Kodama, K.
Takahashi, M. Shichiri, S. Horiuchi, Eur. J. Biochem. 1995, 230, 408.
[43] T. Areschoug, S. Gordon, Cell. Microbiol. 2009, 11, 1160.
[44] U. Smole, C. Radauer, N. Lengger, M. Svoboda, N. Rigby, M.
Bublin, S. Gaier, K. Hoffmann-Sommergruber, E. Jensen-Jarolim, D.
Mechtcheriakova, H. Breiteneder, PLoS One 2015, 10, e0117904.
[45] L. Delamarre,M. Pack, H. Chang, I. Mellman, E. S. Trombetta, Science
2005, 307, 1630.
[46] M. Egger, A. Jurets, M. Wallner, P. Briza, S. Ruzek, S. Hainzl, U. Pich-
ler, C. Kitzmuller, B. Bohle, C. G. Huber, F. Ferreira, PLoS One 2011,
6, e17278.
Mol. Nutr. Food Res. 2018, 62, 1800341 1800341 (12 of 12) C© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
